Palo Alto-based Spry Health has unveiled its first product — a clinical-grade wearable called Loop which delivers continuous vital sign monitoring. The device is designed for chronically ill patients, providing individualized analytics to improve patient outcomes, reduce hospitalization, and decrease spending by healthcare organizations.
Incubated at Stanford-affiliated accelerator StartX in 2013, founders Pierre-Jean “PJ” Cobut and Elad Ferber started Spry Health with a mission to help chronically ill patients receive proactive care and help them stay out of the hospital.
“In a given year, over 28 million hospitalizations are attributed to chronically ill patients, resulting in an average bill of $37,300 per stay with some patients winding up in the hospital three or more times per year,” Ferber said in a statement.
Loop’s analytics platform pinpoints subtle physiological changes and delivers relevant, actionable insights to healthcare organizations before new symptoms are noticeable to the patient. Healthcare organizations are then able to guide their most vulnerable members to the right care at the right time.
Prior to launching the product, Spry Health conducted comprehensive pre-market evaluations of Loop with more than 250 participants to prove its clinical equivalence against standards of care for blood pressure, heart rate, oxygen saturation, respiration, and CO2 monitoring.
The company has submitted the wearable for FDA (510k) clearance and is expected to get the green light by early 2018.